Simeon Siegel, BMO Capital Markets senior retail analyst, joins 'Power Lunch' to discuss the upbeat holiday retail sales data ...

Evan Siegerman, BMO biotech analyst, joins 'Power Lunch' to discuss the big winners in the pharmaceutical space in 2025.

BMO Capital lowered the firm’s price target on Novo Nordisk (NVO) to $105 from $156 and keeps an Outperform rating on the shares after ...

Coming off of Novo Nordisk's (NVO) sharp stock decline after its experimental weight-loss shot CagriSema was found to help recipients lose less weight than previously forecasted, BMO Capital Markets ...

BMO Junior Gold Index ETF (TSE:ZJG – Get Free Report)’s share price traded down 0.7% on Tuesday . The stock traded as low as C$92.56 and last traded at C$92.56. 652 shares changed hands during mid-day ...

ETF investors should consider BMO Low Volatility Canadian Equity ETF (TSX:ZLB) and another income-oriented option.

With a $500-million budget, the Calgary Municipal Land Corporation (CMLC) managed to deliver the BMO Centre expansion this ...

Bank of Montreal closed C$8.13 short of its 52-week high of C$147.54, which the company reached on December 6th.

said Scott Anderson, Chief U.S. Economist, BMO. "Yet many are still willing to pay for festive cheer even while feeling anxious about the cost of living, driving some overall holiday spending growth." ...

BMO offers both a Smart Fixed closed mortgage and a fixed-rate closed mortgage. Here’s the difference between the two: With any closed mortgage, you can prepay a certain amount each year without ...

BMO Capital downgraded Biogen (BIIB) to Market Perform from Outperform with a price target of $164, down from $230. Work is underway at Biogen, ...

BMO’s prime rate was lowered to 5.45% on December 11, 2024, following the Bank of Canada rate announcement. BMO’s prime rate is the basis for its variable-rate lending products, like mortgages ...